Letter from Frank Hill Chairman of the UKHCDO to the Haemophilia Centre Directors regarding the allocation of phased funds to allow haemophilia patients aged 23 and over to be treated with recombinant products
Letter from Frank Hill Chairman of the UKHCDO to the Haemophilia Centre Directors regarding the allocation of phased funds to allow haemophilia patients aged 23 and over to be treated with recombinant products